Pre-Clinical SIG (previously TOX SIG)
To provide a forum to discuss and advance statistical topics related to Research, Discovery (including efficacy models), Regulatory and Investigative Toxicology/Safety Assessment and to promote the involvement of Statisticians in these areas.
Who we are
Our membership consists of statisticians at CROs, pharmaceutical companies and academia who are working in areas such as:
- Good statistical practice in in-vitro, ex-vivo and in-vivo assay development
- Reproducibility and Translation from pre-clinical to clinical
- Genetic Toxicology
- Acute Toxicology
- General Toxicology
- DMPK / Pharmacokinetics
- Immuno Toxicology
- Developmental and Reproductive Toxicology
We discuss diverse topics ranging from Dog Telemetry data analysis to Decision Trees, from Bayesian methods to dealing with irate study directors, and now have a list of over 50 affiliates on our e-mail distribution list.
The PSI Pre-clinical Special Interest Group have a series of regular FREE webinars dealing with statistical topics faced in pre-clinical and related fields. The presentations will run for an hour, with approximately 45 min presentation and a Q&A session in the remaining time. See section below for details of this year’s webinars.
The PSI Pre-Clinical Special Interest Group seminars for 2021 are as follows:
|Slides/Video on Demand|
Beyond the looking glass – Interpreting animal welfare & behaviour by monitoring & assessing mice activity data
Eloisa Brook, Joanna Moore, George Birbeck. GSK
Update from the Carcinogenicity working group
Steve Bailey. Pfizer
Dr Brianna Gaskill. Novartis
For all previous webinars click here.
We are already planning for when we are able to hold face-to-face workshops again. Watch this space.
How to get in touch
Join our mailing list by e-mailing this address with brief details of the field(s) you are working in.